Predicting protein homocysteinylation targets based on dihedral strain energy and pKa of cysteines
- 12 December 2007
- journal article
- research article
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 71 (3) , 1475-1483
Abstract
A multitude of complex diseases have been linked to elevated homocysteine levels; however, till date there is no plausible explanation for a single amino acid's involvement in so many diseases. Since homocysteine is a reactive thiol amino acid and the majority of plasma homocysteine is protein thiol bound, we hypothesized that homocysteine might bind to accessible cysteine residues in target proteins, thereby modulating its structure or function or both. The parameters that dictate homocysteine–protein interaction are not well understood, and the few known homocysteine binding proteins wereidentified by a candidate protein approach. In this study, we identified potential homocysteine interacting proteins based on cysteine content, solvent accessibility of cysteine residues, and dihedral strain energies and pKa of these cysteines. Pathway mapping of the cysteine‐rich proteins revealed that proteins in the coagulation cascade, notch receptor‐mediated signaling, LDL endocytosis, programmed cell death, and extracellular matrix proteins were significantly over‐represented with cysteine‐rich proteins, and we believe that homocysteine has a high probability to bind to proteins in these pathways. In fact, several clinical studies have implicated high homocysteine levels to be associated with diseases like thrombosis, neural tube defects, and so forth, which result from dysfunction of one or more of the proteins identified in our study. Further, we successfully validated our prediction parameters on the proteins that have already been experimentally shown to bind homocysteine, and our structural analysis argues a plausible explanation for these prior reported protein interactions with homocysteine that could not be previously explained. Proteins 2008.Keywords
This publication has 64 references indexed in Scilit:
- Molecular targeting by homocysteine: a mechanism for vascular pathogenesisClinical Chemistry and Laboratory Medicine (CCLM), 2005
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- Relative Roles of Albumin and Ceruloplasmin in the Formation of Homocystine, Homocysteine-Cysteine-mixed Disulfide, and Cystine in CirculationJournal of Biological Chemistry, 2001
- Albumin Thiolate Anion Is an Intermediate in the Formation of Albumin-S–S-HomocysteineJournal of Biological Chemistry, 2001
- Hyperhomocysteinaemia and protein S deficiency in complicated pregnanciesBJOG: An International Journal of Obstetrics & Gynaecology, 1997
- Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British menThe Lancet, 1995
- Homocysteinemia is a common feature of schizophreniaJournal of Neural Transmission, 1995
- Homocysteine metabolism in pregnancies complicated by neural-tube defectsThe Lancet, 1995
- Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.Journal of Clinical Investigation, 1986